The report covers all life instruments and associated reagents used in pharmaceuticals, biotechnology and diagnostics that help cutting edge research and innovative application. These technologies include from basic to advanced technologies, this report does not include medical devices or in-vitro diagnostics market; however the usage of instruments and reagents for diagnostic purpose is included in the market.
The cell analysis market is expected to grow steadily in the forecast period. Improved accuracy of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process is the major factor driving the market.
A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next Generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days.
Cell expansion process plays a key role in therapeutic development, drug screening and core research. It is used for improving the outcome of transplantation and diseases such as rheumatoid arthritis and diabetes. New technology such as 3D cell expansion technology is accelerating the growth of this market.
Over the last several decades, technologies for identification, isolation, sequencing, replication and integration of desired genes in target organisms have transformed tremendously, emergence of genome editing technology is set to bring a paradigm shift in gene modification approaches.
Spectrometry uses electromagnetic radiations for qualitative and quantitative sample analysis so as to obtain structural data and identify chemical makeup of a sample. Spectrometry provides results accuracy and rapidly increasing productivity, efficiency resulting in reduced cost.
Cell-free DNA are small fragments of DNA circulating freely in the blood and body fluids which are utilized as a valuable biomarker to advance personalized medicine, and improve the quality of life. The factors driving the growth of this market are raising number of late pregnancies leading to high incidence rates of babies with chromosomal disorders, increasing number of life threatening cancer and infectious diseases are likely to propel the market.
Polymerase Chain Reaction is a process in which multiple copies of desired DNA sequence is obtained in a short period of time. The factors driving the growth of this market are increasing demand for innovative technology supporting early and accurate diagnosis of life threatening disease, rising demand for PCR in genetic and molecular testing and expiry of key players PCR patents.
The 3D cell culture global market is poised to grow at a double digit CAGR to reach $3,702.2 million by 2021. Rise in Research and Development Investments, rising need for organ transplantation, Use of 3D cell culture models as an alternative tool for invivo testing, microfluidic technology and increasing focus on regenerative medicine are set to drive the market.
The global biochips market is expected to grow at a CAGR of around 18.0 % by 2020. Revolution in the field of genomics, proteomics as well as rapid drug discovery, increase in diagnosis and treatment of cancer and genetic diseases, are the factors driving the market
This report would help the client in understanding the insights about market trends, dynamics, and in depth analysis of products/technologies, applications and other segments of Genomics global market. In addition, the research study also includes the future opportunities, technological advancements and competitive landscaping of major players in the Genomics industry.